Good News
A Gentle Quiet for Baby Adnan

From his very first day of life, little Adnan endured a battle no baby should ever have to face, suffering a seizure roughly every thirteen minutes. For his devoted family, watching him endure over one hundred seizures a day was heartbreaking. But today, I am filled with so much joy to share that peace and calm have finally arrived at his bedside.
At King’s College Hospital London in Dubai, a dedicated medical team sequenced Adnan’s entire genome and discovered a specific gene variant responsible for his rare genetic epilepsy. Led by consultant pediatric neurologist Professor Ubaid Shah, the hospital applied to the Dubai Health Authority for compassionate use of an experimental oral drug called ABS-1230. The medication targets abnormal activity in an ion channel, and Adnan became the youngest patient in the world—and only the second infant ever—to receive it.
When the treatment was administered on September 14th, the relief was immediate and profound. His seizures stopped entirely. Just a week later, Adnan was able to go home with his family without having experienced a single seizure during that time. Subsequent checks through November 2nd show he remains seizure-free and is already reaching his early developmental milestones. While doctors emphasize that close monitoring and further research continue, seeing this sweet baby get the chance to simply rest, grow, and thrive warms my heart completely.
The 508 Takeaway
When innovative precision medicine meets compassionate, determined care, life-changing relief becomes possible. Seeing Adnan move from constant turmoil into calm days reminds us of the profound hope that scientific dedication brings to our world’s smallest fighters.
This story was originally reported by Andy Corbley. You can read the full original article here.
Source
Andy Corbley